Halaman 2 - Leiomiosarkoma Dokter Terbaik - TOP-62 dokter

Dokter lulus dari Fakultas Kedokteran Universitas Ankara dan menyelesaikan pelatihan residensi dalam bidang penyakit dalam di Fakultas Kedokteran GATA Ankara. Mengkhususkan diri dalam onkologi medis dan hematologi, dokter menyelesaikan fellowship klinis di AS. Sebagai pelopor di Turki, dokter adalah bagian dari tim yang melakukan transplantasi sumsum tulang pertama di negara tersebut. Dokter telah menjadi dosen tamu di lembaga-lembaga bergengsi di London dan Swiss. Memegang Sertifikat Onkologi Medis Eropa, dokter adalah anggota pendiri dari baik Masyarakat Onkologi Medis Turki maupun Kelompok Onkologi Turki. Fokus klinis termasuk kanker payudara, gastrointestinal, paru-paru, limfoma, dan mieloma.<\/p>

Dr. Tahsin Ozadli adalah spesialis onkologi medis dengan pelatihan ekstensif di Rumah Sakit Onkologi Ankara.

• Spesialisasi dalam kanker paru-paru, esofagus, dan lambung
• Bekerja di Klinik Onkologi Medis Rumah Sakit Onkologi Ankara
• Menerbitkan penelitian di bidang onkologi – lihat profil Google Scholar

Prof. Elke Jaeger mengepalai Onkologi dan Hematologi di Nordwest – dinobatkan sebagai salah satu ahli onkologi terbaik di Jerman oleh Focus.

• 39 tahun pengalaman spesialisasi di bidang onkologi
• Melakukan 1.100+ prosedur
• Profesor Onkologi Interdisipliner
• Anggota komite ahli EORTC

Dr. Alemdar berspesialisasi dalam onkologi medis dengan pelatihan ekstensif di Universitas Akdeniz, sebuah institusi terkemuka di Turki.

• Tersertifikasi dewan dalam onkologi medis sejak 2018
• Pengalaman lebih dari 15 tahun di bidang penyakit dalam dan onkologi
• Pernah bekerja di Rumah Sakit Universitas Akdeniz, yang dikenal dengan perawatan kanker tingkat lanjut

Prof. Dr. Ozcan Yildiz memiliki lebih dari satu dekade penelitian khusus dan publikasi dalam kasus onkologi yang kompleks. Beliau merawat pasien di Rumah Sakit Universitas Medipol Mega.

• Penulis berbagai studi tentang tumor langka seperti kanker neuroendokrin dan neuroektodermal
• Keahlian mencakup penanganan sindrom paraneoplastik terkait kanker dan presentasi yang tidak biasa
• Berpengalaman dalam mengelola efek samping kompleks dari terapi kanker tingkat lanjut
• Anggota jaringan penelitian onkologi profesional, berkontribusi pada literatur medis

Dr. Levin memimpin program sarkoma pediatrik di Sourasky Medical Center dan menempuh studi di Rizzoli Orthopaedic Institute Italia yang terkemuka di dunia.

• Memiliki pengalaman lebih dari 30 tahun dalam hematologi dan onkologi pediatrik
• Spesialisasi dalam tumor tulang dan sarkoma jaringan lunak pada anak-anak
• Dokter spesialis anak senior di Rumah Sakit Anak Dana di Tel Aviv
• Direktur departemen hematologi-onkologi pediatrik di Sourasky
• Anggota Masyarakat Hematologi Onkologi Pediatrik Israel

Prof. Köstler adalah seorang onkolog medis terkemuka yang berspesialisasi dalam terapi target, dengan pengalaman lebih dari 20 tahun dalam kanker payudara dan ginekologi di Wiener Privatklinik.

• Associate Professor di Universitas Kedokteran Wina
• Wakil Kepala Divisi Klinis Onkologi
• Ahli dalam pengembangan biomarker dan biologi tumor
• Mempublikasikan karya di jurnal onkologi internasional terkemuka

Professor Keil berspesialisasi dalam pencitraan penampang dan radiologi intervensi, menerapkan teknik canggih seperti MRI, CT, dan ultrasonografi untuk perencanaan diagnosis dan perawatan yang tepat.

• Lulus dengan pujian dari Julius-Maximilians-Universität Würzburg
• Memimpin Klinik Radiologi Diagnostik dan Intervensi di Rumah Sakit Universitas Aachen
• Menjabat sebagai Kepala Dokter di Rumah Sakit Akademik Solingen
• Menjadi ahli dalam MRI dan CT untuk pola penyakit yang kompleks

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

30+ tahun di bidang imunologi – Dr. Jaunalksne memiliki spesialisasi dalam viroterapi, sebuah pendekatan mutakhir untuk modulasi sistem imun.

• Memimpin Pusat Imunologi Klinis di Rumah Sakit Universitas Klinis Pauls Stradins
• Lulus dari Institut Medis Riga dengan magang di Kedokteran Internal
• Berfokus pada perawatan imunologi inovatif

Prof. Madya Nail Paksoy spesialis dalam Leiomyosarkoma di Rumah Sakit Medipol Bahcelievler, dengan Sertifikasi Dewan ESMO dalam Onkologi Medis.

• Menerbitkan penelitian tentang kemoterapi dosis tinggi untuk Sarkoma Ewing
• Sub-peneliti dalam 8 uji klinis internasional untuk kanker stadium lanjut
• Beasiswa Onkologi Medis di Institut Onkologi Universitas Istanbul
• Anggota ESMO dengan keahlian dalam perawatan sarkoma

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.